BioLineRx (BLRX) Reports In-Line Q2 EPS

BioLineRx (NASDAQ: BLRX) reported Q2 EPS of $0.00. Revenue for the quarter came in at $5.39 million.

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• GeneDx (WGS) PT Raised to $63 at Piper Sandler
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance